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Natural killer cells (NK) secrete eosinophilotactic cytokines, however, whether they contribute to eosinophil chemotaxis by
secreting IL-8 is not known. We investigated the ability of CD56+CD3-ve (NK cells) to induce chemotaxis of peripheral blood
eosinophilsfromallergicrhinitis(AR)patients,throughIL-8secretion,andtheeﬀectsofIL-15,theNKcellproactivatingcytokine,
and calcitriol: 1α, 25-dihydroxy Vitamin D3 (vitamin D3), the immunomodulator agent, in this scenario. Herein, it is shown that
supernatantsfromunstimulatedNKcellsexhibitedchemotacticactivityagainsteosinophil.Thiseﬀectwassigniﬁcantlyaugmented
by IL-15 (1ng/mL) treatment, resulting in an increase in the chemotactic index of approximately 3 folds and was abrogated by
neutralizing antibody (Ab) to IL-8 in a dose-dependent fashion. The amount of IL-8 secreted by NK cells was increased by IL-
15 treatment from levels of 88.64 ± 21.5 to 178.9 ± 23.6Pg/mL and was signiﬁcantly reduced by 10−6 M vitamin D3 to levels of
59.2 ± 16.3Pg/mL. Our results indicate a novel inﬂammatory crosstalk between NK cells and eosinophils via IL-15/IL-8 axis that
can be modulated by vitamin D3.
1.Introduction
IL-8 is a potent activator for eosinophil chemotaxis in
vitro and in vivo [1]. IL-8 also possesses a clear role in
eosinophil chemotaxis in allergic respiratory diseases [2, 3].
On the other hand, IL-15 eﬀect on human eosinophil is
through inhibition of the spontaneous apoptosis via the
autocrine production of GM-CSF and thus may perpetuate
allergic inﬂammation by prolonged eosinophil survival [4].
Nonetheless, the role of IL-15 in the pathophysiology of
allergic airways diseases is still in its infancy and remains a
controversial issue [5–9].
NK cells activation plays a pivotal role in viruses and
tumor lyses [10]; however, they also produce cytokines
and thus are thought to play a proinﬂammatory role [11].
The secretagogue activity of NK cells includes IFN-γ,I L -
10, TNF-α, MIP-1, MIP-1β, and GM-CSF. These cytokines
are augmented by IL-15, a cytokine produced by acti-
vated monocytes/macrophages [12, 13]. Some investigators
demonstrated the ability of NK cells to diﬀerentiate in the
presence of IL-4 into NK cell subsets secreting distinct
cytokines patterns similar to TH2 proﬁle such as IL-5 and IL-
13 [14, 15]. A more recent study demonstrated the existence
of type 2 cytokine-secreting NK cells in AR and showed
increased number and enhanced cytotoxicity of NK cells
[16]. This highlights a novel role for NK cells in allergic
diseases. Nonetheless, whether NK cells are able to attract
eosinophils through IL-8 secretion is not known.
Increasing evidence supports a novel immunoregulatory
role for vitamin D in allergic diseases such as asthma and AR
[17, 18]. The ability of vitamin D to reduce cytokines from
inﬂammatory cells is also well acknowledged. Therefore, the
therapeutic potential of vitamin D as an anti-inﬂammatory
agent in allergic diseases remains a subject of interest.2 Mediators of Inﬂammation
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Figure 1: Eosinophilotactic activity of supernatants of resting NK
cells versus supernatants of NK cells stimulated with IL-15. Results
are the mean ± SEM of 10 independent experiments performed in
triplicate. Asterisks indicate P<0.05 by paired t-test.
Herein, we show a novel crosstalk between human NK
cell and eosinophil recruitment through IL-15/IL-8 axis.
Results are discussed in relation to the possible novel ther-
apeutic eﬀect of vitamin D in downregulating this inﬂam-
matory event, and the possible role for NK cells in the pa-
thophysiology of AR.
2.MaterialsandMethods
2.1. Cell Preparation. Eosinophils and NK cells were isolated
by Percoll (66%) solution. NK cells were isolated from
buﬀy coats to obtain large amount of cells for culture
purposes, and eosinophils were freshly isolated from the
peripheralbloodofsixteenARpatientssensitizedtodiﬀerent
aeroallergens that were conﬁrmed by skin tests and/or
radioallergosorbent test (RAST). Eosinophils and NK cells
were further puriﬁed by negative selection immunomagnetic
cell separation (MACS; Miltenyi Biotec, Bergisch Gladbach,
Germany), using anti-CD16 magnetic beads for eosinophils
puriﬁcation, and a cocktail of biotin-conjugated antibodies
againstlineage-speciﬁcantigensandacocktailofmicrobeads
(NK Cell Isolation Kit-human, Miltenyi Biotec, Bergisch
Gladbach, Germany) for NK (CD56+ve CD3-ve) cells puriﬁ-
cation. Cells purity was >96% for both cell types. Cells
viability was always >98% as judged by trypan blue.
2.2. Cell Culture. NK cells (1 × 106 cells) were incubated
in the presence or absence of 1ng/mL IL-15 (R&D Sys-
tems; Minneapolis, MN), 10−6 M concentration of vitamin
D3 (Cayman Chemical), 10−5 M concentration of H-89 Di-
hydrochloride (VWR-CALBIOCHEM), a PKA inhibitor,
10−5 M concentration of Bisindolylmaleimide (VWR-
CALBIOCHEM), a PKC inhibitor, 10−5 M concentration
of SB203580 (VWR-CALBIOCHEM), a P38 MAP-Kinase
inhibitor, or 1μM concentration of Genistein (Sigma),
a tyrosine kinase inhibitor, at 37◦C-5% CO2 with 1mL
RPMI-1640 supplemented with 100Upenicillin/mL and
100μg streptomycin/mL (Lonza, Verviers, Belgium), 10%
of inactivated fetal calf serum (Lonza) in 24 wells plate (BD
biosciences).After72hincubationperiod,supernatantswere
carefully collected and analysed for their eosinophilotactic
activity or IL-8 content.
As for the measurement of IL-8 content induced by
peripheral blood NK cells from AR patients before and after
nasalchallenge,peripheralbloodNKcellswerepuriﬁedfrom
additionalfourARpatientstohousedustmite(HDM).After
obtaining the patients consent, 30mls of peripheral blood
was obtained before and 6 hours after nasal challenge with
HDM allergen. Puriﬁed NK cells at the concentration of
3 × 106 cells/mL were incubated in the culture medium for
72hrs. Supernatants were collected and the amount of IL-8
was measured by ELISA.
2.3. Chemotaxis Assays. Chemotaxis assays were performed
in triplicate in a 48-well microchemotaxis Boyden chambers
incubatedin5%CO2 at37◦Cfor90min.Aliquotsof29μLof
the NK supernatant were placed in the lower wells and 50μL
of eosinophils suspension (106 cells/mL) were placed in the
upper wells. The two chambers were separated by a 5.0μm
pore polycarbonate membrane (Nuclepore, Whatman, Mid-
dlesex, UK). Migrated cells adherent to the lower surface
were counted in 5 selected high power ﬁelds/well under a
light microscope (5hpf; X400). As for blocking experiments,
NK supernatants were preincubated for 1h and during the
chemotaxis assay, with diﬀerent doses (10−8–10−6 g/mL) of
the monoclonal anti-IL-8Ab that neutralizes the biological
activity of IL-8 (R&D systems; Minneapolis. MN).
2.4. Enzyme-Linked Immunosorbant Assay (ELISA). The
content of IL-8 was measured in supernatants of NK cells
using human IL-8 cytoset Kit (Invitrogen corporation, USA)
according to the manufacturers’ recommendations.
2.5. Statistical Analysis. Statistical signiﬁcance was per-
formed by paired t-test. Values of P<0.05 were considered
signiﬁcant.
3. Results
3.1. NK Cells Supernatants-Induced Eosinophil Chemotaxis.
NK cells supernatants induced chemotaxis of eosinophils
from AR patients (Figure 1). NK cells treatment with the
optimal dose of 1ng/mL IL-15 during the culture period
resultedinsigniﬁcantaugmentationofNKcellssupernatant-
induced eosinophil chemotaxis from AR patients to almost
3-fold chemotaxis index. These results indicate a novel
autocrine activity for NK cells in recruiting eosinophils and
highlight a novel role for IL-15 in up-regulating this eﬀect.Mediators of Inﬂammation 3
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IL-8 Ab (10−8 g/mL)
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Figure 2: Eﬀect of neutralizing IL-8 antibody on eosinophils
chemotaxis against IL-15-induced NK cells supernatants. Results
are the mean ± SEM of 6 independent experiments performed in
triplicate. Asterisk indicates P<0.05 by paired t-test.
3.2. Blocking Activity of Anti-IL8 Ab. Figure 2 shows that
eosinophil chemotaxis of AR patients against NK super-
natant of cells treated by IL-15 was signiﬁcantly blocked by
anti-IL-8 Ab. The blocking activity was in a dose-dependent
fashion, but was not completely blocked to the control level.
These results indicate that NK cells stimulated by IL-15
secrete eosinophilotactic chemokines that include at least in
part IL-8 among others. To conﬁrm this, we next measured
by ELISA the amount of IL-8 spontaneously secreted by NK
cells, and the modulatory eﬀects of IL-15 and vitamin D3 on
IL-8 secretion.
3.3. Modulation of the Amount of Secreted IL-8 in NK Cells
Supernatant by IL-15 and Vitamin D3. We tested the amount
of IL-8 secreted by NK cells after 72h culture period in
the presence and absence of the optimal doses of IL-15
or vitamin D3.A sc a nb es e e ni nTable 1,c u l t u r e dN K
cells for 72h secreted IL-8. The amount of recovered IL-
8 was increased from 88.64 ± 21.5t o1 7 8 .9 ± 23.6Pg/mL
and was signiﬁcantly reduced by vitamin D3 to 59.2 ±
16.3Pg/mL. These results indicate the ability of IL-15 to
upregulate the IL-8 secretagogue activity by NK cells, and
the ability of vitamin D3 to signiﬁcantly inhibit the IL-8
secretagogue activity of NK cells. Furthermore, it conﬁrms
the contribution of IL-8 to the eosinophilotactic cytokines
secreted by NK cells.
However, to gain insight into the possible signal pathway
involved in NK cell induced-IL-8 modulation by IL-15
and vitamin D3,w et r e a t e dN Kc e l l sw i t hd i ﬀerent kinases
inhibitors during the culture period. H-89 Dihydrochloride,
Bisindo-lylmaleimide, or Genistein did not modulate the
amount of IL-8 secreted by NK cells (data not shown).
Table 1:AmountofIL-8recoveredinsupernatantsofNKcellsafter
72 h culture period.
Stimulant IL-8 (Pg/mL) in NK cells supernatants
RPMI 88.6 ± 21.5
IL-15 (1ng/mL) 178.9 ± 23.6
Vit D3 (10–6M) 59.2 ± 16.3∗∗∗
SB203580 (10–5M) 15 ± 0.5∗∗∗
IL-15 (1ng/mL) +
SB203580 (10–5M) 54.75∗∗∗
Results are ±SEM of 4–8 independent experiments. Asterisks indicate P<
0.05 by paired t-test.
H o w e v e r ,a sc a nb es e e ni nTable 1,I L - 8s e c r e t i o nb yN K
cells was sensitive to SB203580 and resulted in reduction of
IL-8 to 15 ± 0.5Pg/mL. Similarly, the augmentation of IL-8
secretion by IL-15 was reduced by SB203580 to 54.75 ± 5.7.
These results may indicate the involvement of P38 MAP-
Kinase pathway in the signal transduction of IL-8 secretion
by NK cells.
3.4. Modulation of the Amount of Secreted IL-8 in NK Cells
Supernatant from AR Patients after Nasal Challenge. Finally
to further correlate our results to the pathophysiology of
AR, we challenged AR patients to HDM with HDM allergen.
N Kc e l l sp u r i ﬁ c a t i o nb e f o r ea n da t6 hp o s t c h a l l e n g ew e r e
cultured for 72h. Collected supernatants were checked by
ELISA for the amount of IL-8 recovered. As demonstrated in
Figure 3,afternasalchallengeNKcellssecretedasigniﬁcantly
higher amount of IL-8. This result indicates the importance
of NK cells as a source for IL-8 in the pathophysiology of AR.
4. Discussion
In the current communication, we demonstrated a novel
crosstalk between NK cells and eosinophils via IL-15/IL-8
axis. This may indicate a role for IL-15 in the pathophysiol-
ogy of allergic rhinitis late-phase reaction and the promotion
of eosinophilic inﬂammation.
In AR disease, the mixed in vivo milieu of TH2 cytokines
especially induced after allergen exposure prime eosinophils.
This makes them exhibit distinct phenotype and exaggerated
responses to chemokines such as IL-8 [19]. Herein, we show
that nasal allergen challenge of AR patients also primes
NK cells to secrete larger amounts of IL-8. Further, the
ability of NK cells to secrete IL-8 in their supernatants that
contributedtothe attractionofeosinophils fromAR patients
may provide a further explanation to eosinophil recruitment
in AR.
IL-15 prolongs eosinophil survival and thus acts as a
proeosinophilic inﬂammatory mediator [4]. In the current
study, IL-15 demonstrated a further novel indirect role in
helping eosinophil recruitment, at least in part through
secretion of IL-8 from resting NK cells.
Vitamin D binds to its nuclear receptor, the vitamin
D receptor (VDR) through which it signals in its target
cells. We demonstrated a signiﬁcant inhibition of IL-8 by4 Mediators of Inﬂammation
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Figure 3: Amount of IL-8 secreted by NK cells of AR patients
sensitized to HDM before and 6h after nasal challenge with
HDM allergen. Results are the mean ± SEM of 4 independent
experiments. Asterisks indicate P<0.05 by paired t-test.
NK cells in the presence of Vitamin D3. This is consistent
with an earlier study that demonstrated that vitamin D3
repressed IL-8 promoter activity induced by TNF-α in
human melanoma cell line by 50% compared to 30%
inhibition by dexamethasone, as well as TNF-α-induced IL-8
release and IL-8 mRNA level [20].
The fact that IL-8 secretion by NK cells was sensitive
to P38 MAP-Kinase inhibition may indicate that IL-15 and
vitamin D3 modulated IL-8 autocrine activity of NK cells
through the same pathway. It is then reasonable to assume
that IL-15 may induce IL-8 secretion by NK cells through
stimulation of P38 MAP-kinase activity and that vitamin
D3 reduces IL-8 secretion from NK cells through blocking
eﬀect on the P38 MAP-Kinase pathway. Nonetheless, further
studies are needed to prove or disprove this hypothesis. In
conclusion, our results may indicate the following:
(1) anovelroleforNKcellsinthepathophysiologyofAR
through recruiting eosinophils,
(2) a novel modulatory role for IL-15 in inducing eos-
inophils chemotaxis from AR patients through the
NK cells secretagogue activity,
(3) identifying IL-8 as an important cytokine that con-
tributes to the eosinophilotactic agents secreted by
NK cells,
(4) indicating that vitamin D3 may be an eﬀective ther-
apeutic modality.
Our results open channels for other researchers to further
elaborate on the exact mechanism(s) involved in NK-
induced IL-8 modulation by IL-15 and vitamin D3 and P38
MAP-Kinase inhibition.
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